ITEC PACKAGING (CHESTER-LE-STREET) LIMITED

Financial Health Score: F

Explanation: The patient is in the Intensive Care Unit. A grade of F reflects a business that is in "Insolvency Proceedings," meaning it has suffered a catastrophic financial event—typically severe cash flow failure or liabilities vastly exceeding assets. The company is no longer operating under the control of its original management or owners, but under the care of external "surgeons" (insolvency practitioners) appointed to salvage what they can.

1. Key Vital Signs

• Corporate Pulse (Company Status): Insolvency Proceedings. The patient's heartbeat is irregular and failing. The business is legally recognized as unable to pay its debts, and a formal recovery or wind-down process has begun.
• Administrative Blood Pressure (Filing Compliance): Critical/Overdue. Both the annual accounts and the confirmation statement are overdue. This is a common symptom when a company enters insolvency; normal administrative functions often collapse as resources and attention are diverted to the emergency proceedings.
• Organ Function (Directorship & Control): Transplanted. The current directors include individuals from FRP Advisory (as indicated by the registered address), who are insolvency practitioners. The original "organs" of the business (the prior management) have been replaced by specialists tasked with performing financial surgery.
• Genetic Lineage (Corporate History & PSCs): Complex/High-Risk. The company has changed its name seven times since 1990, indicating a long history of corporate restructuring, mergers, or acquisitions. The People with Significant Control (PSCs) include private equity entities (Breal Capital, Sun Capital Partners via Marc Leder and Rodger Krouse) and a Luxembourg-based holding company. This complex, private-equity-backed lineage often involves heavy financial engineering and high debt loads, which can be a chronic condition leading to acute distress.

2. Diagnosis

The diagnosis is Acute Corporate Insolvency with Complex Private Equity Etiology.

The financial data reveals a business that has suffered a terminal failure of its vital systems. While the company has a substantial share capital figure of £9.9 million, this is largely a historical artifact representing funds injected or restructured over its 30+ year history, rather than available cash. In insolvency, equity is typically wiped out by overwhelming liabilities.

The presence of FRP Advisory at the registered address and the appointment of insolvency practitioners as directors confirm that the company is under the equivalent of a medical conservatorship. The overdue filings at Companies House are a secondary symptom—a fever caused by the underlying illness—indicating that the company's routine administrative immune system has shut down.

The frequent name changes and the layered, international private equity ownership suggest a history of being passed between investment groups, which often results in a business being loaded with debt or starved of operational investment. This chronic condition has culminated in the current acute crisis.

3. Recommendations

Because the company is in insolvency, traditional financial wellness advice (like "cut costs" or "improve margins") no longer applies. The focus must shift from prevention to triage and damage control:

• For Creditors (The Blood Donors): Cease all extension of credit. Register your claims with the appointed insolvency practitioners immediately. Expect significant haircuts (losses) on outstanding debts.
• For Employees (The Cells): Seek advice from the Insolvency Service regarding redundancy payments and outstanding wages. The business is under the control of practitioners whose legal duty is to creditors, not necessarily to preserve jobs.
• For the Insolvency Practitioners (The Surgeons): The priority is to stem the bleeding. This typically involves evaluating whether a "pre-pack" sale of the healthy assets (the viable parts of the business) can be achieved quickly to preserve some value, or whether an orderly wind-down and asset liquidation is the only path.
• For the Parent Companies (The Genetic Donors): The PSCs (Breal Capital, Sun Capital, etc.) must decide whether to provide emergency life support (debenture funding) to keep the business alive long enough for a sale, or to cut their losses and allow the entity to be struck off.